Jones William Benton has filed 6 insider transactions across 1 company since May 2024.
Most recent transaction: a grant/award of 400000 shares of Corvus Pharmaceuticals, Inc. ($CRVS) on December 04, 2025.
Activity breakdown: 2 open-market purchases and 0 sales.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Dec. 4, 2025 | Corvus Pharmaceuticals, Inc. | $CRVS | Jones William Benton | See Remarks | A | Stock Option (Right to Buy) | 400000 | $0.00 | 400,000.0000 | 82,836,369 | 9999.99% | 0.48% |
| June 4, 2025 | Corvus Pharmaceuticals, Inc. | $CRVS | Jones William Benton | See Remarks | M | Common Stock | 19357 | $3.50 | 173,130.0000 | 75,152,514 | 12.59% | 0.03% |
| June 4, 2025 | Corvus Pharmaceuticals, Inc. | $CRVS | Jones William Benton | See Remarks | M | Warrant (Right to Buy) | 19357 | $0.00 | 0.0000 | 75,152,514 | 100.00% | 0.03% |
| Dec. 20, 2024 | Corvus Pharmaceuticals, Inc. | $CRVS | Jones William Benton | See Remarks | A | Stock Option (Right to Buy) | 300000 | $0.00 | 300,000.0000 | 66,701,086 | 9999.99% | 0.45% |
| May 6, 2024 | Corvus Pharmaceuticals, Inc. | $CRVS | Jones William Benton | See Remarks | P | Common Stock | 20000 | $1.73 | 153,773.0000 | 49,038,582 | 14.95% | 0.04% |
| May 6, 2024 | Corvus Pharmaceuticals, Inc. | $CRVS | Jones William Benton | See Remarks | P | Warrant (Right to Buy) | 19357 | $0.00 | 19,357.0000 | 49,038,582 | 9999.99% | 0.04% |